News
GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...
MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
17h
CivicScience on MSNGLP-1 Trends by CivicScience: Access and Shortages, Desire for Customized Products, and Self-Care PreferencesThis is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their prescribed obesity medication, according to findings published in Obesity.
So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
A mother from Rhondda Cynon Taf, in Wales has shared tips to prevent common side effects of the weight loss jab Mounjaro.
15h
Flow Space on MSNThe Newest Nutrition Guidelines for GLP-1 Users Will Make Sure You're at Your HealthiestIt’s also key to ensure that patients still get a wide variety of nutrients, including tons of protein, to prevent any nutritional deficiencies. Medical management of any G.I. side effects, which can ...
Investing.com -- Allurion Technologies Inc (NYSE: ALUR) stock rose 2.9% following the announcement of a strategic distribution partnership with Minogue Medical Inc., a Canadian medical device company ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results